comparemela.com

Latest Breaking News On - Eterna therapeutics inc - Page 7 : comparemela.com

Short Interest in Eterna Therapeutics Inc. (NASDAQ:ERNA) Rises By 261.2%

Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) was the recipient of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 134,000 shares, an increase of 261.2% from the December 15th total of 37,100 shares. Based on an average daily trading volume, of 34,300 […]

Eterna-therapeutics-inc
Eterna-therapeutics-company-profile
Vanguard-group-inc
Goldman-sachs-group-inc
Geode-capital-management
Renaissance-technologies
Nasdaq
Eterna-therapeutics
Get-free-report
Sachs-group
Capital-management

Brooklyn ImmunoTherapeutics (NYSE:BTX) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report published on Sunday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance NYSE BTX opened at $1.89 on Friday. The company has a market cap of $111.18 million, a P/E ratio of -0.83 and a beta […]

Brooklyn-immunotherapeutics
Eterna-therapeutics-inc
Renaissance-technologies
Brooklyn-immunotherapeutics-inc
Securities-exchange-commission
Brooklyn-immunotherapeutics-company-profile
Free-report
Get-free-report
Nyse-btx
Kbtx
Information
Initiated-coverage

Brooklyn ImmunoTherapeutics (NYSE:BTX) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report released on Sunday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance Brooklyn ImmunoTherapeutics stock opened at $1.87 on Friday. Brooklyn ImmunoTherapeutics has a 1-year low of $0.17 and a 1-year high of $10.10. The firm […]

Brooklyn-immunotherapeutics
Renaissance-technologies
Exchange-commission
Brooklyn-immunotherapeutics-inc
Eterna-therapeutics-inc
Free-report
Get-free-report
Nyse-btx
Kbtx
Information
Initiated-coverage
Stocknews-com

Brooklyn ImmunoTherapeutics (NYSE:BTX) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note released on Saturday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Up 4.7 % NYSE BTX opened at $1.88 on Friday. The firm’s 50 day moving average is $1.45 and its 200-day moving average […]

Brooklyn-immunotherapeutics
Eterna-therapeutics-inc
Brooklyn-immunotherapeutics-inc
Renaissance-technologies
Free-report
Get-free-report
Nyse-btx
Kbtx
Information
Initiated-coverage
Stocknews-com

Brooklyn ImmunoTherapeutics (NYSE:BTX) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report sent to investors on Saturday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance Brooklyn ImmunoTherapeutics stock opened at $1.88 on Friday. Brooklyn ImmunoTherapeutics has a 1 year low of $0.17 and a 1 year […]

Brooklyn-immunotherapeutics
Renaissance-technologies
Brooklyn-immunotherapeutics-inc
Eterna-therapeutics-inc
Exchange-commission
Brooklyn-immunotherapeutics-company-profile
Free-report
Get-free-report
Nyse-btx
Kbtx
Information
Initiated-coverage

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.